Company Filing History:
Years Active: 2007
Title: Matheus Hubertus Maria Noteborn: Innovator in Gene Delivery Technologies
Introduction
Matheus Hubertus Maria Noteborn is a notable inventor based in Leiderdorp, Netherlands. He has made significant contributions to the field of gene delivery technologies, particularly in the development of innovative therapies for cancer treatment. His work focuses on utilizing viral proteins to induce apoptosis in tumor cells while sparing normal cells.
Latest Patents
Noteborn holds a patent for a gene delivery vehicle that expresses the apoptosis-inducing proteins VP2 and/or apoptin. This invention relates to gene delivery vehicles that comprise nucleic acid molecules encoding these proteins, which are derived from the Chicken Anaemia Virus. The technology aims to enhance anti-tumor therapies by selectively inducing apoptosis in various human tumor cells while minimizing effects on normal, non-malignant cells. Additionally, the invention has implications for the diagnosis of cancer and related conditions such as hyperplasia, metaplasia, and dysplasia.
Career Highlights
Matheus Noteborn is associated with Leadd B.V., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of gene therapy, contributing to innovative solutions for cancer treatment.
Collaborations
Noteborn collaborates with various professionals in his field, including his coworker Alexandra Maria Pietersen. Their combined expertise enhances the potential for breakthroughs in gene delivery technologies.
Conclusion
Matheus Hubertus Maria Noteborn is a pioneering inventor whose work in gene delivery vehicles represents a significant advancement in cancer therapy. His innovative approach to utilizing viral proteins for targeted treatment showcases the potential for future developments in medical science.